Latest News about TVTX
Recent news which mentions TVTX
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
December 12, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022
December 05, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 22, 2022
From Benzinga
Travere Therapeutics Earnings Perspective: Return On Capital Employed
November 03, 2022
Tickers
TVTX
From Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
From Benzinga
Earnings Scheduled For October 27, 2022
October 27, 2022
From Benzinga
121 Stocks That Hit Their 52-Week Low
October 14, 2022
From Benzinga
FDA Requests For Additional Monitoring For Travere Therapeutics' Sparsentan In Rare Kidney Disease
October 14, 2022
Tickers
TVTX
From Benzinga
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
October 05, 2022
From InvestorPlace
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 22, 2022
From Benzinga
Travere, CSL's Sparsentan Application Is Under European Review For Rare Kidney Disorder
August 22, 2022
From Benzinga
Tickers
TVTX
From Best Stocks
From Benzinga
FDA Says Travere's Sparsentan Data Not Sufficient For Accelerated Approval In One Indication
August 04, 2022
Tickers
TVTX
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 03, 2022
From Benzinga
From Benzinga
HC Wainwright & Co. Maintains Buy Rating for Travere Therapeutics: Here's What You Need To Know
May 17, 2022
Tickers
TVTX
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.